Cargando…
Lysozyme nephropathy in chronic myelomonocytic leukemia
Lysozyme nephropathy is a frequently unrecognized cause of renal disease in chronic myelomonocytic leukemia and may serve as a novel indication for treatment in this patient population. We demonstrate that in newly diagnosed CMML patients, plasma lysozyme levels are positively correlated with both a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553339/ https://www.ncbi.nlm.nih.gov/pubmed/31183108 http://dx.doi.org/10.1002/ccr3.2188 |
| _version_ | 1783424796817620992 |
|---|---|
| author | Patel, Ami B. Miles, Rodney R. Deininger, Michael W. |
| author_facet | Patel, Ami B. Miles, Rodney R. Deininger, Michael W. |
| author_sort | Patel, Ami B. |
| collection | PubMed |
| description | Lysozyme nephropathy is a frequently unrecognized cause of renal disease in chronic myelomonocytic leukemia and may serve as a novel indication for treatment in this patient population. We demonstrate that in newly diagnosed CMML patients, plasma lysozyme levels are positively correlated with both absolute monocyte count and serum creatinine. |
| format | Online Article Text |
| id | pubmed-6553339 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65533392019-06-10 Lysozyme nephropathy in chronic myelomonocytic leukemia Patel, Ami B. Miles, Rodney R. Deininger, Michael W. Clin Case Rep Clinical Images Lysozyme nephropathy is a frequently unrecognized cause of renal disease in chronic myelomonocytic leukemia and may serve as a novel indication for treatment in this patient population. We demonstrate that in newly diagnosed CMML patients, plasma lysozyme levels are positively correlated with both absolute monocyte count and serum creatinine. John Wiley and Sons Inc. 2019-05-10 /pmc/articles/PMC6553339/ /pubmed/31183108 http://dx.doi.org/10.1002/ccr3.2188 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Clinical Images Patel, Ami B. Miles, Rodney R. Deininger, Michael W. Lysozyme nephropathy in chronic myelomonocytic leukemia |
| title | Lysozyme nephropathy in chronic myelomonocytic leukemia |
| title_full | Lysozyme nephropathy in chronic myelomonocytic leukemia |
| title_fullStr | Lysozyme nephropathy in chronic myelomonocytic leukemia |
| title_full_unstemmed | Lysozyme nephropathy in chronic myelomonocytic leukemia |
| title_short | Lysozyme nephropathy in chronic myelomonocytic leukemia |
| title_sort | lysozyme nephropathy in chronic myelomonocytic leukemia |
| topic | Clinical Images |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553339/ https://www.ncbi.nlm.nih.gov/pubmed/31183108 http://dx.doi.org/10.1002/ccr3.2188 |
| work_keys_str_mv | AT patelamib lysozymenephropathyinchronicmyelomonocyticleukemia AT milesrodneyr lysozymenephropathyinchronicmyelomonocyticleukemia AT deiningermichaelw lysozymenephropathyinchronicmyelomonocyticleukemia |